Yajing You - Publications

Survival of Patients with Hepatitis B-Related Hepatocellular Carcinoma with Concomitant Metabolic Associated Fatty Liver Disease.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: April 08, 2023

Phosphorylation of RGS16 at Tyr168 promote HBeAg-mediated macrophage activation by ERK pathway to accelerate liver injury.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: March 27, 2023

FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease.

Journal: Free radical biology & medicine

Published: September 28, 2022

ATRA-mediated-crosstalk between stellate cells and Kupffer cells inhibits autophagy and promotes NLRP3 activation in acute liver injury.

Journal: Cellular signalling

Published: January 01, 2022

EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli.

Journal: Cell death & disease

Published: November 02, 2021

Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: June 03, 2021

TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: January 27, 2019

The role of microfluidics in protein formulations with pre-programmed functional characteristics.

Journal: Biologics : targets & therapy

Published: December 26, 2018

Correction to: TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.

Journal: Cell death & disease

Published: October 11, 2018

TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.

Journal: Cell death & disease

Published: January 21, 2018